37 related articles for article (PubMed ID: 23455184)
1. Expression of preoperative KISS1 gene in tumor tissue with epithelial ovarian cancer and its prognostic value.
Cao F; Chen L; Liu M; Lin W; Ji J; You J; Qiao F; Liu H
Medicine (Baltimore); 2016 Nov; 95(46):e5296. PubMed ID: 27861355
[TBL] [Abstract][Full Text] [Related]
2. CD137 ligand-mediated reverse signaling inhibits proliferation and induces apoptosis in non-small cell lung cancer.
Qian Y; Pei D; Cheng T; Wu C; Pu X; Chen X; Liu Y; Shen H; Zhang W; Shu Y
Med Oncol; 2015 Mar; 32(3):44. PubMed ID: 25631633
[TBL] [Abstract][Full Text] [Related]
3. Ring finger protein 43 expression is associated with genetic alteration status and poor prognosis among patients with intrahepatic cholangiocarcinoma.
Talabnin C; Janthavon P; Thongsom S; Suginta W; Talabnin K; Wongkham S
Hum Pathol; 2016 Jun; 52():47-54. PubMed ID: 26980022
[TBL] [Abstract][Full Text] [Related]
4. Different prognostic factors correlate with Bcl-2 expression among triple negative and non-triple negative breast cancers.
Abd El-Hafez A; Shawky Mohamed Ael-A; Elesawy BH
Asian Pac J Cancer Prev; 2013; 14(2):1037-41. PubMed ID: 23621182
[TBL] [Abstract][Full Text] [Related]
5. Control of Wnt Receptor Turnover by R-spondin-ZNRF3/RNF43 Signaling Module and Its Dysregulation in Cancer.
Hao HX; Jiang X; Cong F
Cancers (Basel); 2016 Jun; 8(6):. PubMed ID: 27338477
[TBL] [Abstract][Full Text] [Related]
6. Mesothelin-Targeted CARs: Driving T Cells to Solid Tumors.
Morello A; Sadelain M; Adusumilli PS
Cancer Discov; 2016 Feb; 6(2):133-46. PubMed ID: 26503962
[TBL] [Abstract][Full Text] [Related]
7. c-Met Overexpression in Cervical Cancer, a Prognostic Factor and a Potential Molecular Therapeutic Target.
Refaat T; Donnelly ED; Sachdev S; Parimi V; El Achy S; Dalal P; Farouk M; Berg N; Helenowski I; Gross JP; Lurain J; Strauss JB; Woloschak G; Wei JJ; Small W
Am J Clin Oncol; 2017 Dec; 40(6):590-597. PubMed ID: 26083558
[TBL] [Abstract][Full Text] [Related]
8. Expression of BCL-2 proto-oncogene in adult acute lymphoblastic leukemia.
Campos L; Sabido O; Sebban C; Charrin C; Bertheas MF; Fière D; Guyotat D
Leukemia; 1996 Mar; 10(3):434-8. PubMed ID: 8642858
[TBL] [Abstract][Full Text] [Related]
9. An emerging role for BAG3 in gynaecological malignancies.
De Marco M; Falco A; Iaccarino R; Raffone A; Mollo A; Guida M; Rosati A; Chetta M; Genovese G; De Caro F; Capunzo M; Turco MC; Uversky VN; Marzullo L
Br J Cancer; 2021 Sep; 125(6):789-797. PubMed ID: 34099896
[TBL] [Abstract][Full Text] [Related]
10. Knockdown of Bcl-2-Associated Athanogene-3 Can Enhance the Efficacy of BGJ398 via Suppressing Migration and Inducing Apoptosis in Gastric Cancer.
Li K; Deng X; Feng G; Chen Y
Dig Dis Sci; 2021 Sep; 66(9):3036-3044. PubMed ID: 33089486
[TBL] [Abstract][Full Text] [Related]
11. Development of an anti-BAG3 humanized antibody for treatment of pancreatic cancer.
Basile A; De Marco M; Festa M; Falco A; Iorio V; Guerriero L; Eletto D; Rea D; Arra C; Lamolinara A; Ballerini P; Damiani V; Rosati A; Sala G; Turco MC; Marzullo L; De Laurenzi V
Mol Oncol; 2019 Jun; 13(6):1388-1399. PubMed ID: 30973679
[TBL] [Abstract][Full Text] [Related]
12. Silencing Bag-1 gene via magnetic gold nanoparticle-delivered siRNA plasmid for colorectal cancer therapy in vivo and in vitro.
Huang W; Liu Z; Zhou G; Ling J; Tian A; Sun N
Tumour Biol; 2016 Aug; 37(8):10365-74. PubMed ID: 26846101
[TBL] [Abstract][Full Text] [Related]
13. Expression and clinical role of antiapoptotic proteins of the bag, heat shock, and Bcl-2 families in effusions, primary tumors, and solid metastases in ovarian carcinoma.
Elstrand MB; Kleinberg L; Kohn EC; Tropé CG; Davidson B
Int J Gynecol Pathol; 2009 May; 28(3):211-21. PubMed ID: 19620938
[TBL] [Abstract][Full Text] [Related]
14. Clinical impact of high mobility group box 1 protein in epithelial ovarian cancer.
Paek J; Lee M; Nam EJ; Kim SW; Kim YT
Arch Gynecol Obstet; 2016 Mar; 293(3):645-50. PubMed ID: 26305032
[TBL] [Abstract][Full Text] [Related]
15. FOXM1 expression is significantly associated with chemotherapy resistance and adverse prognosis in non-serous epithelial ovarian cancer patients.
Tassi RA; Todeschini P; Siegel ER; Calza S; Cappella P; Ardighieri L; Cadei M; Bugatti M; Romani C; Bandiera E; Zanotti L; Tassone L; Guarino D; Santonocito C; Capoluongo ED; Beltrame L; Erba E; Marchini S; D'Incalci M; Donzelli C; Santin AD; Pecorelli S; Sartori E; Bignotti E; Odicino F; Ravaggi A
J Exp Clin Cancer Res; 2017 May; 36(1):63. PubMed ID: 28482906
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of several biomarkers in epithelial ovarian cancer: a meta-analysis of published studies.
Xu L; Cai J; Yang Q; Ding H; Wu L; Li T; Wang Z
J Cancer Res Clin Oncol; 2013 Aug; 139(8):1257-77. PubMed ID: 23595127
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic strategies in epithelial ovarian cancer.
Kim A; Ueda Y; Naka T; Enomoto T
J Exp Clin Cancer Res; 2012 Feb; 31(1):14. PubMed ID: 22330607
[TBL] [Abstract][Full Text] [Related]
18. Expression of Bcl-2 and the antiapoptotic BAG family proteins in ovarian cancer.
Aust S; Pils S; Polterauer S; Horvat R; Cacsire Castillo-Tong D; Pils D; Dudek G; Schmid B; Speiser P; Reinthaller A; Grimm C
Appl Immunohistochem Mol Morphol; 2013 Dec; 21(6):518-24. PubMed ID: 23455184
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
